Showing results (2101-2110 of 2,162) with videos related to

Sort By:
Pageof 217
Frontiers in Oncology|March 31, 2022
Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1Zhaoqing Li, Cong Chen, Lini Chen, et al.
Cell Metabolism|May 7, 2020
Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic SteatohepatitisChongshu Jian, Jiajun Fu, Xu Cheng, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|February 9, 2010
[The survival analysis of the advanced metastatic castration-resistant prostate cancer]Chun-guang Ma, Ding-wei Ye, Xu-dong Yao, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|May 2, 2021
Parameters Indicating Development of Influenza-Associated Acute Necrotizing Encephalopathy: Experiences from a Single CenterSuyun Li, Dandan Hu, Peiqing Li, et al.
Nature Genetics|February 2, 2010
Mutations in PNKP cause microcephaly, seizures and defects in DNA repairJun Shen, Edward C Gilmore, Christine A Marshall, et al.
Ebiomedicine|December 12, 2018
Installation of a cancer promoting WNT/SIX1 signaling axis by the oncofusion protein MLL-AF9Li-Shu Zhang, Xunlei Kang, Jianming Lu, et al.
BJU International|November 11, 2014
Visceral fat accumulation is associated with different pathological subtypes of renal cell carcinoma (RCC): a multicentre study in ChinaHong-Kai Wang, Xi-Shuang Song, Yue Cheng, et al.
Frontiers in Immunology|March 25, 2026
PD0325901 alleviates thrombin-inhibited osteogenic differentiation through an IL-1β-activated feedback loop between MEK-Erk1/2 and NF-κB signal pathways: insights from bioinformatics and experimental verificationYang-Shuo Ge, Chun-Meng Huang, Jun Shen, et al.
Blood|July 1, 2010
Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitutionRonjon Chakraverty, Guillermo Orti, Michael Roughton, et al.
Renal Failure|May 6, 2025
The efficacy and safety of rituximab monotherapy in the new onset pediatric idiopathic nephrotic syndrome: a randomized controlled clinical trialAi-Qin Sheng, Fei Liu, Qiu-Yu Li, et al.
Pageof 217